About Angela Steinauer
Angela Steinauer’s lab focuses on the engineering of non-viral, protein-based nanocarriers for targeted RNA delivery. Inspired by viral nucleic acid-protein assemblies, her group adopts a bottom-up approach and utilizes protein design, biomolecular engineering, and directed evolution to construct carriers with tailored functionalities.
Angela Steinauer was born and raised in the small town of Gross, near Einsiedeln (SZ) in Switzerland. She pursued her bachelor’s and master’s studies in chemistry at the University of Zurich, graduating in 2012. She then relocated to the United States to complete her Ph.D. in Chemical Biology at Yale University, supervised by Prof. Alanna Schepartz. During her Ph.D., she was honored with the Howard Hughes Medical Institute International Student Research Fellowship. After receiving her doctorate in 2018, Angela Steinauer returned to Switzerland to join ETH Zurich. Her first postdoctoral work in the Hilvert Lab at ETH Zurich focused on the characterization of protein cages for RNA delivery applications and was supported by the Marie Skłodowska-Curie Actions Postdoctoral Fellowship. She then undertook a one-year postdoctoral position in the Leroux group at ETH, with a focus on the engineering of mucolytic enzymes. Angela Steinauer now leads the Laboratory of Biomolecular Engineering and Nanomedicine (LIBN) at EPFL, where she aims to develop protein-based gene carriers by combining the tools of protein engineering and directed evolution.